期刊文献+

间充质干细胞在眼部疾病中的应用研究进展 被引量:1

Potential applications of mesenchymal stem cells in ocular diseases
原文传递
导出
摘要 间充质干细胞(MSC)除了具有干细胞的各项特征外,还具有促进创伤愈合、抗炎和免疫抑制等独特的功能,是目前最具有潜在临床应用价值的细胞之一。利用其不同的功能和特点,MSC已用于多种眼科疾病的治疗研究,如角膜疾病、葡萄膜炎和视网膜疾病等。本文将对近年来MSC在眼部疾病方面的应用研究进展进行综述。(中华胺科杂志,2012,48:956-960) Except for the characteristics of stem cells, mesenchymal stem cells (MSC) have other distinct functions such as prompting wound healing, anti-inflammatory and immunoregulatory ability, which has made them one of the most promising candidates for cell therapy. By taking advantage of their different characteristics and functions, MSC have been exploited in the treatment of many ocular diseases, such as corneal diseases, uveitis and retinal diseases. This paper will review the progress of the applications of MSC in ocular diseases in recent years. (Chin J Ophthalmol, 2012,48:956-960)
出处 《中华眼科杂志》 CAS CSCD 北大核心 2012年第10期956-960,共5页 Chinese Journal of Ophthalmology
关键词 间质干细胞移植 角膜疾病 葡萄膜炎 视网膜疾病 Mesenchymal stem cell transplantation Corneal diseases Uveitis Retinal diseases
  • 相关文献

参考文献3

二级参考文献43

  • 1Remuzzi G, Schieppati A, Ruggenenti E Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med 2002; 346: 1145-1151.
  • 2Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G.Lowenfels AB, et al. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study. Am J Kidney Dis 2000; 35: 157-165.
  • 3Group UKPDS. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713.
  • 4Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008; 359: 1565-1576.
  • 5Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572.
  • 6Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-2559.
  • 7Yamagishi S, Fukami K, Ueda S, Okuda S. Molecular mechanism of diabetic nephropathy and its therapeutic intervention. Current Drug Targets 2007; 8: 952-959.
  • 8Prockop DJ. Marrow stromal cells as stem cells for non-hematopoietic tissues. Science 1997; 276: 71-74.
  • 9Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
  • 10Digirolamo CM, Stokes D, Colter D, Phinney DG,Class R,Prockop DJ. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with greatest potential to propagate and differentiate. Br J Haematol 1999; 107:275-281.

共引文献81

同被引文献17

  • 1Joe AW, Gregory-Evans K. Mesenchymal stem cells and potential applications in treating ocular disease[J], Curr Eye Res, 2010, 35(11): 941-952.
  • 2Fan CG, Zhang QI, Zhou JR. Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord[J]. Stem Cell Rev, 2011, 7(1): 195-207.
  • 3Moretti P, Hatlapatka T, Marten D, et al. Mesenchymal stromal cells derived from human umbilical cord tissues: primitive cells withpotential for clinical and tissue engineering applications[J]. Adv Biochem Eng Biotechnol, 2010, 123: 29-54.
  • 4Mitchell KE, Weiss ML, Mitchell BM, et al. Matrix cells from Wharton's jelly form neurons and glia[J]. Stern Cells, 2003, 21(1): 50-60.
  • 5Donovan P], Gearhart I. The end of the beginning for pluripotent stem cells[J]. Nature, 2001, 414(6859): 92-97.
  • 6Vangsness CT Jr, Sternberg H, Harris L. Umbilical cord tissue offers the greatest number of harvestable mesenchymal stem cells for research and clinical application: a literature review of different harvest sites[J]. Arthroscopy, 2015, 31 (9): 1836-1843.
  • 7Zhao Q, Hu 1, Xiang J, Gu Y, et al. Intranasal administration of human umbilical cord mesenchymal stem cells-conditioned medium enhances vascular remodeling after stroke[J]. Brain Res, 2015, 1624: 489-496.
  • 8Li T, Zhang C, Ding Y, et al. Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway[J]. Oncol Rep, 2015, 34(3): 1469-1477.
  • 9Feng T, Zhang J, Zeng G, et al. Therapeutic potential of umbilical cord mesenchymal stem cells in mice with acute hepatic failure[J]. Int J Artif Organs, 2015, 38(5): 271-276.
  • 10Sarugaser R, Ennis J, Stanford WL, et al. Isolation, propagation, and characterization of human umbilical cord perivascular cells (HUCPVCs) [J]. Methods Mol Biol, 2009, 482: 269-279.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部